DENTSPLY SIRONA (NASDAQ:XRAY) Receives Sell (D-) Rating from Weiss Ratings

Key Points

• DENTSPLY SIRONA has received a Sell (D-) rating from Weiss Ratings, indicating a negative outlook from analysts.
• Price targets for DENTSPLY SIRONA have been lowered by multiple brokerages, with consensus now at $18.00 following recent evaluations.
• The company reported EPS of $0.52 for the last quarter, surpassing expectations despite a revenue decline of 4.9% year-over-year.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report)'s stock had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings in a research note issued on Wednesday,Weiss Ratings reports.

A number of other brokerages have also recently issued reports on XRAY. Barrington Research decreased their price objective on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set an "outperform" rating on the stock in a research note on Friday, August 8th. Evercore ISI decreased their target price on shares of DENTSPLY SIRONA from $17.00 to $13.00 and set an "in-line" rating for the company in a research report on Wednesday. Stifel Nicolaus reduced their price objective on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating for the company in a research report on Friday, August 8th. Wall Street Zen upgraded shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research note on Friday, September 26th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a research note on Friday, September 26th. Two analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, DENTSPLY SIRONA has a consensus rating of "Hold" and a consensus price target of $18.00.

DENTSPLY SIRONA Price Performance

NASDAQ XRAY traded up $0.16 during trading on Wednesday, reaching $12.49. 1,156,533 shares of the company traded hands, compared to its average volume of 2,999,280. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.11 and a current ratio of 1.69. The stock's 50 day moving average price is $13.65 and its two-hundred day moving average price is $14.67. DENTSPLY SIRONA has a 1-year low of $12.14 and a 1-year high of $24.93. The company has a market cap of $2.49 billion, a price-to-earnings ratio of -2.64, a P/E/G ratio of 0.78 and a beta of 0.96.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, beating the consensus estimate of $0.50 by $0.02. The company had revenue of $936.00 million during the quarter, compared to analysts' expectations of $929.67 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The business's revenue for the quarter was down 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.49 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. As a group, analysts anticipate that DENTSPLY SIRONA will post 1.84 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in XRAY. Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of DENTSPLY SIRONA during the 1st quarter worth about $25,000. Brooklyn Investment Group bought a new stake in shares of DENTSPLY SIRONA during the 1st quarter valued at $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of DENTSPLY SIRONA during the 1st quarter valued at $26,000. Trust Co. of Toledo NA OH bought a new stake in shares of DENTSPLY SIRONA during the 2nd quarter valued at $27,000. Finally, Parkside Financial Bank & Trust lifted its position in shares of DENTSPLY SIRONA by 620.6% during the 2nd quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier's stock valued at $27,000 after acquiring an additional 1,477 shares during the period. 95.70% of the stock is owned by institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.